doi: 10.1016/0006-291x(89)91143-1.
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation
Affiliations
- PMID: 2783143
- DOI: 10.1016/0006-291x(89)91143-1
Item in Clipboard
'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation
Biochem Biophys Res Commun.
.
Abstract
The osteoclast is unique in its capacity to resorb bone. An unbalanced increase in this activity causes osteoporosis, a crippling bone disease that poses a major public health problem. Despite this, our understanding of osteoclast regulation is very limited. Calcitonin is the only known physiological inhibitor of osteoclast function. We demonstrate here for the first time that the concentration of calcium ions at the resorptive site directly regulates osteoclast function by modulating the intracellular free calcium concentration. This represents an important feedback mechanism of osteoclast control.
Similar articles
-
Divalent cations mimic the inhibitory effect of extracellular ionised calcium on bone resorption by isolated rat osteoclasts: further evidence for a "calcium receptor".J Cell Physiol. 1991 Dec;149(3):422-7. doi: 10.1002/jcp.1041490310. J Cell Physiol. 1991. PMID: 1660481
-
Direct effect of calcium channel antagonists on osteoclast function: alterations in bone resorption and intracellular calcium concentrations.Endocrinology. 1994 Sep;135(3):996-1003. doi: 10.1210/endo.135.3.8070395. Endocrinology. 1994. PMID: 8070395
-
Intracellular calcium in the control of osteoclast function. I. Voltage-insensitivity and lack of effects of nifedipine, BAYK8644 and diltiazem.Biochem Biophys Res Commun. 1990 Feb 28;167(1):183-8. doi: 10.1016/0006-291x(90)91748-h. Biochem Biophys Res Commun. 1990. PMID: 1690001
-
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2936-40. doi: 10.1073/pnas.88.7.2936. Proc Natl Acad Sci U S A. 1991. PMID: 1849281 Free PMC article.
-
Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.Adv Drug Deliv Rev. 2005 May 25;57(7):959-71. doi: 10.1016/j.addr.2004.12.018. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15876398 Review.
Cited by
-
Mechanisms balancing skeletal matrix synthesis and degradation.Biochem J. 2002 Jun 1;364(Pt 2):329-41. doi: 10.1042/BJ20020165. Biochem J. 2002. PMID: 12023876 Free PMC article. Review.
-
The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.Int J Hematol. 2003 Dec;78(5):443-9. doi: 10.1007/BF02983818. Int J Hematol. 2003. PMID: 14704038
-
CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.J Cell Biol. 1999 Sep 6;146(5):1161-72. doi: 10.1083/jcb.146.5.1161. J Cell Biol. 1999. PMID: 10477767 Free PMC article.
-
Calcium signalling and calcium transport in bone disease.Subcell Biochem. 2007;45:539-62. doi: 10.1007/978-1-4020-6191-2_21. Subcell Biochem. 2007. PMID: 18193652 Free PMC article. Review.
-
Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1.Front Physiol. 2024 Jan 19;15:1342024. doi: 10.3389/fphys.2024.1342024. eCollection 2024. Front Physiol. 2024. PMID: 38312316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
